Loading
No insider purchase over the last 90 days. The latest was filed 26 Jun 2023.
SiriusPoint Ltd: what insiders have been doing
SiriusPoint Ltd is a Banks company. Its directors and officers file their transactions with SEC (Form 4). Over the twelve months to 18 October 2026, 43 filings were filed, from 8 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Over the last twelve months, not one insider purchase of SiriusPoint Ltd stock was filed. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade.
Compared with its exchange (5,816 companies, median 19 filings), a count of 43 filings is above the norm. The full history, which starts in 2021, counts 5 purchases against 3 sales. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 3.21 bn USD and net income at 459.6 m USD.
Other companies in the same sector with recent insider buying flagged by our signals: First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
197
Thresholds
n/a
Buy Volume
€239,967
5 ops. · all time
Sell Volume
€39M
3 ops. · all time
Who traded when
BuySaleDaniel S. Loeb1 sale
Rafe de la Gueronniere1 sale
Since the insiders bought
- +37.0%Entry US$8.88 · Close at T+365 US$12.17
- +40.1%Entry US$9.31 · Close at T+365 US$13.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 2,246 of 24,148 companies
74.5
score / 100
Value74
Quality75
FCF yld3.5%
Earn yld15%
EV/EBITDA8.2x
ROE23%
Gross mgn·
Net mgn14%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$25.48
Analyst consensus
4 analysts2.00/5
US$25.00Target US$28.25(+11%)US$31.00
Income statement
RevenueUS$3.2B
EBITDAUS$445.7M14% margin
Net incomeUS$443.3M16.8% margin
Valuation
PER (trailing)6.2x
PER (forward)9.2x
P/Book1.3x
Beta0.61
Balance sheet & cash
Market capUS$3B
Total debtUS$688.6M
Free Cash FlowUS$102.4M
Debt / Equity31%
Profitability & ownership
ROE23.1%
ROA2.2%
% insiders11.7%
% institutions87.3%
Last declaration on 29 May 2026
Declarations197 total
5,903 shares@ US$23.290.0044% mcap32.3% of flowCommon SharesSEC:0001628280-26-039217:0
48,625 shares0Common SharesSEC:0001945908-26-000007:0
19,926 shares0Common SharesSEC:0001776629-26-000008:0
5,895 shares0Common SharesSEC:0002050327-26-000008:0
10,717 shares0Common SharesSEC:0002130045-26-000007:0
775,029 shares0Common SharesSEC:0001945908-26-000007:1
775,029 shares0Common SharesSEC:0001945908-26-000007:2
10,766 shares0Common SharesSEC:0001968249-26-000006:0
12,746 shares0Common SharesSEC:0002129304-26-000014:0
15,180 shares0Common SharesSEC:0001654782-26-000003:0
15,622 shares0Common SharesSEC:0002129304-26-000009:3
4,622 shares@ US$22.670.0035% mcap2.0% of flowCommon SharesSEC:0001945908-26-000004:2
2,719 shares@ US$22.670.0021% mcap2.8% of flowCommon SharesSEC:0001968249-26-000004:2
1,702 shares@ US$18.721.6% of flowCommon SharesSEC:0002129304-26-000009:4
10,372 shares@ US$18.729.8% of flowCommon SharesSEC:0002129304-26-000009:5
36,152 shares@ US$22.670.028% mcap91.5% of flowCommon SharesSEC:0002130045-26-000004:0
72,375 shares@ US$22.670.055% mcap75.9% of flowCommon SharesSEC:0001968249-26-000004:0
161,185 shares@ US$22.670.12% mcap77.2% of flowCommon SharesSEC:0001776629-26-000005:0
42,360 shares@ US$22.670.032% mcap47.9% of flowCommon SharesSEC:0002129304-26-000012:0
2,354 shares@ US$22.670.0018% mcap2.7% of flowCommon SharesSEC:0002129304-26-000012:1
3,120 shares@ US$22.670.0024% mcap3.5% of flowCommon SharesSEC:0002129304-26-000012:3
2,009 shares@ US$22.670.0015% mcap5.1% of flowCommon SharesSEC:0002130045-26-000004:1
1,341 shares@ US$22.670.0010% mcap3.4% of flowCommon SharesSEC:0002130045-26-000004:2
138,421 shares@ US$22.670.11% mcap61.3% of flowCommon SharesSEC:0001945908-26-000004:0
7,690 shares@ US$22.670.0059% mcap3.4% of flowCommon SharesSEC:0001945908-26-000004:1
25 of 197 declarations
About SiriusPoint Ltd
SiriusPoint Ltd (ticker: SPNT) is an international specialty insurance and reinsurance group listed on the NYSE in the United States. For investors, it sits in the mid-cap specialty insurance space, where underwriting expertise, portfolio construction and capital discipline matter more than pure premium volume. The company was incorporated under the laws of Bermuda on October 6, 2011, and its current form was created through the merger completed on February 26, 2021 between Sirius International Insurance Group and Third Point Reinsurance. SiriusPoint is headquartered in Bermuda, with a material operating footprint that also includes New York and other major insurance centers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1576018/000157601826000032/spnt-20251231.htm?utm_source=openai))
SiriusPoint’s business model is built around two core pillars: insurance and reinsurance. The group writes Property & Casualty as well as Accident & Health business, spanning specialty insurance programs, treaty reinsurance and Lloyd’s-linked activities in the London market. That mix gives the company exposure to multiple pricing cycles and allows it to focus on risk segments where technical underwriting can be better aligned with expected loss costs. Its recent SEC disclosures indicate licenses to operate in the United States, Bermuda, London and Sweden, with business written across North America, Europe and other global markets. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1576018/000157601826000032/spnt-20251231.htm?utm_source=openai))
Read moreShow less
From a competitive standpoint, SiriusPoint positions itself as a specialist carrier with a diversified, multi-line platform and an underwriting-first philosophy. The company targets brokers, MGAs, insurers and cedants that need capacity in niche and specialty lines, rather than commodity insurance. Its market credibility is supported by financial strength ratings, which are important in reinsurance and specialty insurance relationships. The combination of global licenses, a Bermuda-based balance sheet and access to the London market gives SiriusPoint a meaningful operating platform in a sector where credibility, capital strength and speed of execution are key differentiators. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1576018/000157601826000032/spnt-20251231.htm?utm_source=openai))
Recent developments suggest an ongoing strategic reshaping. In its 2025 annual report, SiriusPoint described a continued effort to simplify the portfolio and sharpen the underwriting focus. On March 16, 2026, the company announced a new operating structure built around four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and a London Market Specialty division that includes Lloyd’s. The company also announced in January 2026 that it intended to redeem all of its Series B preference shares, reinforcing the view that capital management remains an active priority. For investors, SPNT is therefore best understood as a NYSE-listed United States-linked specialty insurer/reinsurer with an international footprint, a disciplined underwriting profile and an emphasis on portfolio optimization. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1576018/000157601826000032/spnt-20251231.htm?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
